Securities code: Apt Medical Inc(688617) securities abbreviation: Apt Medical Inc(688617) Announcement No.: 2022012 Apt Medical Inc(688617)
Announcement of resolutions of the 14th meeting of the first board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
Apt Medical Inc(688617) (hereinafter referred to as “the company”) the 14th meeting of the first board of supervisors was held on March 9, 2022 in the form of on-site combined with communication. There were 3 supervisors who should attend the meeting, and 3 supervisors actually attended, accounting for 100% of the number of supervisors who should attend. The convening and convening procedures of this meeting of the board of supervisors comply with the provisions of the articles of association and relevant laws and regulations. After deliberation and voting by the supervisors present at the meeting, the following resolutions were formed at the meeting: first, the proposal on the company’s annual report 2021 and its summary was deliberated and adopted
After deliberation, the procedures for the company’s management to prepare and review the company’s 2021 annual report and its abstract comply with laws, administrative regulations and the provisions of the CSRC. The contents of the report truly, accurately and completely reflect the actual situation of the company, and there are no false records, misleading statements or major omissions.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. 2、 Deliberated and passed the proposal on the company’s 2021 annual financial report
After deliberation, the company’s 2021 financial report is prepared in accordance with the relevant requirements of the accounting standards for business enterprises, which truly and accurately reflects the company’s financial situation and operating results in 2021. Lixin Certified Public Accountants (special general partnership) hired by the company issued standard unqualified audit opinions, which fairly reflected the company’s financial situation and operating performance.
3、 Deliberated and passed the proposal on the company’s 2021 annual financial statement report
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. 4、 The proposal on the 2022 annual financial budget report of the company was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. 5、 The proposal on the company’s profit distribution plan for 2021 was reviewed and approved
After deliberation, the profit distribution plan of the company in 2021 complies with the provisions of relevant laws, regulations and the articles of association, takes full account of the company’s operating conditions in 2021, daily production and operation needs, sustainable development and other factors, conforms to the actual situation of the company’s current business development, and performs the corresponding decision-making procedures. Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. 6、 The proposal on the company’s self-evaluation report on internal control in 2021 was deliberated and adopted
After deliberation, the company’s internal control self-evaluation work in 2021 meets the requirements of the basic norms of enterprise internal control, and the conclusion of internal control self-evaluation is true and effective. The company’s self-evaluation report on internal control in 2021 comprehensively, objectively and truly reflects the actual situation of the construction and operation of the company’s internal control system. Voting results: 3 in favor, 0 against and 0 abstention.
7、 The proposal on the company’s new / renewed bank credit line in 2022 was deliberated and adopted
After deliberation, the comprehensive credit line applied by the company is necessary for the normal operation of the company, which is conducive to the sustainable and stable operation of the company, and is reasonable and necessary. It is agreed that the company will add / renew the bank credit line in 2022.
Voting results: 3 in favor, 0 against and 0 abstention.
8、 The proposal on the company’s use of temporarily idle self owned funds to purchase financial products in 2022 was deliberated and adopted
After deliberation, it is agreed that the company and its subsidiaries intend to use their own funds of no more than 500 million yuan (including 500 million yuan) for cash management. The term shall not exceed 12 months from the date of deliberation and approval by the board of directors of the company. Purchase investment products with high safety, good liquidity and controllable risk without affecting the normal development of the main business of the company and its subsidiaries and ensuring the operating capital demand of the company. This matter will not affect the needs of the company’s daily capital turnover and the normal development of the company’s main business, and will not damage the interests of the company and all shareholders.
Voting results: 3 in favor, 0 against and 0 abstention.
9、 The proposal on employing the company’s audit institution in 2022 was deliberated and adopted
After deliberation, the company continues to employ Lixin Certified Public Accountants (special general partnership) as the company’s audit institution in 2022 to provide relevant consulting services such as accounting statement audit for the company, which is in line with the relevant provisions of the company law of the people’s Republic of China and the articles of association, and in line with the actual situation and long-term development needs of the company, It is conducive to safeguarding the long-term interests of all shareholders of the company now and in the future, and there is no damage to the interests of shareholders. Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. 10、 The proposal on the special report on the deposit and actual use of the company’s annual raised funds in 2021 was reviewed and approved
After deliberation, The deposit and use of the company’s annual raised funds in 2021 comply with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the Listing Rules of the science and Innovation Board of Shanghai Stock Exchange, the regulatory guidelines for listed companies No. 2 – regulatory requirements for the management and use of raised funds of listed companies and other laws and regulations, as well as the company’s raised funds management system And other regulations, carried out special account storage and special use of the raised funds, and timely fulfilled the relevant information disclosure obligations. The special report on the deposit and actual use of the company’s raised funds in 2021 is true, accurate and complete, without false records, misleading statements and major omissions. It truthfully reflects the actual deposit and use of the company’s raised funds in 2021, and there is no violation of the deposit and use of raised funds.
Voting results: 3 in favor, 0 against and 0 abstention.
11、 Deliberating the proposal on purchasing directors, supervisors and senior managers’ liability insurance
After deliberation, the company plans to purchase the director supervisor high liability insurance from the insurance company, which is conducive to further improving the company’s risk management system, improving the corporate governance level, reducing operational risks, promoting the directors, supervisors, senior managers and relevant responsible persons of the company to more fully exercise their rights and perform their duties within their respective responsibilities, and protecting the rights and interests of the company and investors. The deliberation procedure of this matter is legal and compliant, and there is no situation that damages the interests of the company and all shareholders.
Voting results: 0 in favor, 0 against and 0 abstention. All supervisors of the company avoided voting on this proposal and directly submitted it to the 2021 annual general meeting of shareholders of the company for deliberation.
12、 The proposal on the work report of the board of supervisors in 2021 was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
13、 Review the proposal on the remuneration of the company’s supervisors in 2021 and the remuneration scheme in 2022
Voting results: 0 in favor, 0 against and 0 abstention. All supervisors of the company avoided voting on this proposal and directly submitted it to the 2021 annual general meeting of shareholders of the company for deliberation. 14、 The proposal on Revising the management system of Apt Medical Inc(688617) preventing the controlling shareholders and related parties from occupying the company’s funds was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
15、 The proposal on Amending the Apt Medical Inc(688617) articles of Association was deliberated and adopted. The voting results were: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. 16、 The proposal on Amending the rules of procedure of Apt Medical Inc(688617) shareholders’ meeting was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. 17、 The proposal on Amending the rules of procedure of the Apt Medical Inc(688617) board of supervisors was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. 18、 The proposal on Amending the management system of Apt Medical Inc(688617) connected transactions was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. 19、 Deliberated and adopted the proposal on Revising the Apt Medical Inc(688617) foreign investment management system
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. 20、 The proposal on Revising the management system of Apt Medical Inc(688617) external guarantee was deliberated and adopted
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
It is hereby announced.
Apt Medical Inc(688617) board of supervisors March 11, 2022
